Rafferty Asset Management’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-257,560
| Closed | -$901K | – | 1164 |
|
|
2024
Q2 | $901K | Buy |
+257,560
| New | +$901K | ﹤0.01% | 842 |
|
|
2022
Q4 | – | Sell |
-602,451
| Closed | -$2.54M | – | 1134 |
|
|
2022
Q3 | $2.54M | Sell |
602,451
-152,682
| -20% | -$644K | 0.03% | 457 |
|
|
2022
Q2 | $2.11M | Sell |
755,133
-196,954
| -21% | -$550K | 0.02% | 451 |
|
|
2022
Q1 | $5.45M | Buy |
952,087
+390,810
| +70% | +$2.24M | 0.03% | 368 |
|
|
2021
Q4 | $5.12M | Buy |
561,277
+293,809
| +110% | +$2.68M | 0.03% | 382 |
|
|
2021
Q3 | $2.86M | Buy |
267,468
+98,085
| +58% | +$1.05M | 0.02% | 510 |
|
|
2021
Q2 | $2.63M | Sell |
169,383
-27,309
| -14% | -$424K | 0.02% | 562 |
|
|
2021
Q1 | $3.19M | Buy |
196,692
+162,820
| +481% | +$2.64M | 0.02% | 451 |
|
|
2020
Q4 | $717K | Sell |
33,872
-75,112
| -69% | -$1.59M | 0.01% | 600 |
|
|
2020
Q3 | $1.62M | Buy |
108,984
+72,582
| +199% | +$1.08M | 0.02% | 476 |
|
|
2020
Q2 | $535K | Buy |
36,402
+25,952
| +248% | +$381K | 0.01% | 698 |
|
|
2020
Q1 | $123K | Sell |
10,450
-91,030
| -90% | -$1.07M | 0.01% | 552 |
|
|
2019
Q4 | $2.39M | Sell |
101,480
-17,085
| -14% | -$402K | 0.04% | 321 |
|
|
2019
Q3 | $2.19M | Sell |
118,565
-87,689
| -43% | -$1.62M | 0.03% | 330 |
|
|
2019
Q2 | $3.83M | Buy |
206,254
+77,812
| +61% | +$1.45M | 0.07% | 221 |
|
|
2019
Q1 | $3.14M | Buy |
+128,442
| New | +$3.14M | 0.05% | 216 |
|